Literature DB >> 12476349

Glial cell response: A pathogenic factor in Parkinson's disease.

Du Chu Wu1, Kim Tieu, Oren Cohen, Dong-Kug Choi, Miquel Vila, Vernice Jackson-Lewis, Peter Teismann, Serge Przedborski.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of pro-oxidant reactive species, proinflammatory prostaglandin, and cytokines. In this review, the authors discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how these factors may contribute to the pathogenesis of this disease.

Entities:  

Mesh:

Year:  2002        PMID: 12476349     DOI: 10.1080/13550280290100905

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  70 in total

1.  The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.

Authors:  B Mirza; H Hadberg; P Thomsen; T Moos
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  The parkinsonian toxin MPTP: action and mechanism.

Authors:  Serge Przedborski; Vernice Jackson-Lewis; Ruth Djaldetti; Gabriel Liberatore; Miquel Vila; Slobodanka Vukosavic; Gabrielle Almer
Journal:  Restor Neurol Neurosci       Date:  2000       Impact factor: 2.406

4.  Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Authors:  S Przedborski; Q Chen; M Vila; B I Giasson; R Djaldatti; S Vukosavic; J M Souza; V Jackson-Lewis; V M Lee; H Ischiropoulos
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Authors:  S Hunot; N Dugas; B Faucheux; A Hartmann; M Tardieu; P Debré; Y Agid; B Dugas; E C Hirsch
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

6.  Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death.

Authors:  C E Sortwell; B F Daley; M R Pitzer; S O McGuire; J R Sladek; T J Collier
Journal:  J Comp Neurol       Date:  2000-10-09       Impact factor: 3.215

7.  Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

Authors:  C Knott; G Stern; G P Wilkin
Journal:  Mol Cell Neurosci       Date:  2000-12       Impact factor: 4.314

Review 8.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

Authors:  R E Heikkila; B A Sieber; L Manzino; P K Sonsalla
Journal:  Mol Chem Neuropathol       Date:  1989-06

9.  Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denervation.

Authors:  J G Sheng; S Shirabe; N Nishiyama; J P Schwartz
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Glutathione peroxidase, glial cells and Parkinson's disease.

Authors:  P Damier; E C Hirsch; P Zhang; Y Agid; F Javoy-Agid
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

View more
  12 in total

Review 1.  Neural immunity: Friend or foe?

Authors:  Howard E Gendelman
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.

Authors:  S B Foster; H Tang; K E Miller; G Dryhurst
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

4.  Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes.

Authors:  Amanda K Ashley; William H Hanneman; Takeshi Katoh; Julie A Moreno; Ashley Pollack; Ronald B Tjalkens; Marie E Legare
Journal:  Toxicol Lett       Date:  2008-11-21       Impact factor: 4.372

5.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

Review 6.  Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury.

Authors:  Mark Noble; Jeannette E Davies; Margot Mayer-Pröschel; Christoph Pröschel; Stephen J A Davies
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in Rats.

Authors:  Iana Calou; Mary Anne Bandeira; Wellida Aguiar-Galvão; Gilberto Cerqueira; Rafaelly Siqueira; Kelly Rose Neves; Gerly Anne Brito; Glauce Viana
Journal:  Parkinsons Dis       Date:  2014-06-25

Review 8.  Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease.

Authors:  Giulia Sita; Patrizia Hrelia; Andrea Tarozzi; Fabiana Morroni
Journal:  Int J Mol Sci       Date:  2016-09-01       Impact factor: 5.923

9.  Osteopetrotic (op/op) mice have reduced microglia, no Abeta deposition, and no changes in dopaminergic neurons.

Authors:  Yoichi Kondo; Cynthia A Lemere; Timothy J Seabrook
Journal:  J Neuroinflammation       Date:  2007-12-20       Impact factor: 8.322

Review 10.  Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.

Authors:  Sandeep Vasant More; Hemant Kumar; In Su Kim; Soo-Yeol Song; Dong-Kug Choi
Journal:  Mediators Inflamm       Date:  2013-06-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.